Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer

Abstract

Optimal secondary CRS had survival benefit for platinum-sensitive epithelial ovarian cancer. Asymptomatic recurrent was one of the recruited factors for this procedure.